[MMA News Now, May 22, 2014]
On May 21, Gov. Mark Dayton signed a health care omnibus bill that includes several pieces of MMA-backed legislation including new restrictions on e-cigarette use, rules to prohibit minors from using tanning devices and more.
With the new law, e-cigarette use will be banned in many public places including health care facilities, schools and universities, and state buildings. The new law also requires e-cigarettes to be sold from behind the counter with all other tobacco products and enhances localities ability to enforce retailing restrictions.
In addition, children under 18 will no longer be able to access artificial tanning devices. Businesses are further required to post a sign at the point of sale notifying consumers of the new law.
The law also calls for the Prescription Monitoring Program to alert physicians whose patient are potentially doctor shopping for opioids. The law removes a requirement that a prescriber's name be hidden on prescribing records unless the prescriber consents to having it appear. Going forward, all prescribers’ names will be included on individual records.
Plus, the law:
• Requires that all foster parents in Minnesota provide a smoke-free environment for their children
• Mandates that clinics providing mammograms must send notice to patients who have dense breast tissue informing them of their condition and that it may make it more difficult to identify precancerous lesions or cancer through mammograms
• Brings Minnesota’s medication compounding laws in line with federal standards
• Requires the state’s Health Professionals Services Program to report a practitioner to his or her licensing board if that person has exhibited potentially harmful behavior toward a patient or coworker
• Mandates that health licensing boards suspend a health licensee’s license for no more than 30 days when probable cause indicates an imminent risk to patient safety. A formal disciplinary hearing must be held within the 30-day period
• Authorizes data collection by the Minnesota Department of Health on the incidence and treatment of ST elevation myocardial infarction heart attack events
• Enhances the ability of the Board of Pharmacy to police those who sell so-called “synthetic drugs,” which mimic the effects of Schedule I and II drugs.